Published in J Inflamm (Lond) on February 18, 2015
Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature (2017) 1.09
Therapeutic Implications for Overcoming Radiation Resistance in Cancer Therapy. Int J Mol Sci (2015) 0.86
Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting. Vaccines (Basel) (2016) 0.82
Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy-A Hypothesis-Driven Review. Antioxidants (Basel) (2016) 0.76
Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC. Front Immunol (2017) 0.75
l-Alpha Glycerylphosphorylcholine as a Potential Radioprotective Agent in Zebrafish Embryo Model. Zebrafish (2016) 0.75
Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks. Radiat Oncol (2016) 0.75
Increasing the efficacy of radiotherapy by modulating the CCR2/CCR5 chemokine axes. Oncotarget (2016) 0.75
The melatonin immunomodulatory actions in radiotherapy. Biophys Rev (2017) 0.75
Role of Natural Radiosensitizers and Cancer Cell Radioresistance: An Update. Anal Cell Pathol (Amst) (2016) 0.75
IL-4, a direct target of miR-340/429, is involved in radiation-induced aggressive tumor behavior in human carcinoma cells. Oncotarget (2016) 0.75
Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases-Implications for Intraoperative Radiotherapy after Resection. Front Oncol (2017) 0.75
Rescuing Self: Transient Isolation and Autologous Transplantation of Bone Marrow Mitigates Radiation-Induced Hematopoietic Syndrome and Mortality in Mice. Front Immunol (2017) 0.75
Evaluating biomarkers to model cancer risk post cosmic ray exposure. Life Sci Space Res (Amst) (2016) 0.75
The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling. Oncogenesis (2017) 0.75
Immunity, inflammation, and cancer. Cell (2010) 28.27
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell (2003) 25.94
Nuclear factor-kappaB in cancer development and progression. Nature (2006) 18.31
TGFbeta in Cancer. Cell (2008) 17.44
STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer (2009) 15.45
Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol (2002) 14.80
Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol (2013) 5.43
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood (2009) 5.21
Combining immunotherapy and targeted therapies in cancer treatment. Nat Rev Cancer (2012) 5.15
The JAK-STAT signaling pathway: input and output integration. J Immunol (2007) 4.92
Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. J Clin Invest (2001) 4.92
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor beta(1). J Exp Med (2001) 4.71
Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. Lancet Oncol (2013) 4.21
Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer (2011) 4.08
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys (2009) 3.91
The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol (2009) 3.85
Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. Genes Dev (2007) 3.57
A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys (1995) 3.53
Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci U S A (2000) 3.44
Role of HER2 in wound-induced breast carcinoma proliferation. Lancet (2003) 3.40
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?. Ann N Y Acad Sci (2009) 3.27
Combining radiotherapy and cancer immunotherapy: a paradigm shift. J Natl Cancer Inst (2013) 3.07
STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol (2003) 3.04
TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? Int J Radiat Oncol Biol Phys (2000) 2.97
Systemic effects of local radiotherapy. Lancet Oncol (2009) 2.97
Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol (2012) 2.94
Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev (2012) 2.82
TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol (2013) 2.80
Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer (2005) 2.65
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. Cancer Res (2011) 2.60
Overlapping and enzyme-specific contributions of matrix metalloproteinases-9 and -12 in IL-13-induced inflammation and remodeling. J Clin Invest (2002) 2.52
Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res (2003) 2.49
Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol (2003) 2.48
Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci (2006) 2.44
Circulating interleukin-6 predicts survival in patients with metastatic breast cancer. Int J Cancer (2003) 2.36
Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc (2006) 2.30
IL-6 involvement in epithelial cancers. J Clin Invest (2007) 2.29
Cyclooxygenase-2: a therapeutic target. Annu Rev Med (2002) 2.16
Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ (2006) 2.16
Pathogenetic mechanisms in radiation fibrosis. Radiother Oncol (2010) 2.15
Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis (2002) 2.08
Loss of homotypic cell adhesion by epithelial-mesenchymal transition or mutation limits sensitivity to epidermal growth factor receptor inhibition. Mol Cancer Ther (2007) 2.07
Transcription factor NF-kappaB: a sensor for smoke and stress signals. Ann N Y Acad Sci (2005) 2.05
Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res (2007) 2.03
Radiation oncology: a century of achievements. Nat Rev Cancer (2004) 1.98
Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci (2004) 1.96
Constitutively activated Stat3 protects fibroblasts from serum withdrawal and UV-induced apoptosis and antagonizes the proapoptotic effects of activated Stat1. Proc Natl Acad Sci U S A (2001) 1.89
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer (2003) 1.85
The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy. Expert Opin Ther Targets (2010) 1.85
COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nat Rev Drug Discov (2003) 1.82
Inflammation and cancer: how friendly is the relationship for cancer patients? Curr Opin Pharmacol (2009) 1.78
Smad3: a key player in pathogenetic mechanisms dependent on TGF-beta. Ann N Y Acad Sci (2003) 1.74
DNA damage-dependent NF-κB activation: NEMO turns nuclear signaling inside out. Immunol Rev (2012) 1.74
Induction of IL-13 triggers TGF-beta1-dependent tissue fibrosis in chronic 2,4,6-trinitrobenzene sulfonic acid colitis. J Immunol (2007) 1.69
Apoptosis and radiosensitization of hodgkin cells by proteasome inhibition. Int J Radiat Oncol Biol Phys (2000) 1.69
Biological effects of curcumin and its role in cancer chemoprevention and therapy. Anticancer Agents Med Chem (2006) 1.62
Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition. Cancer Res (2007) 1.60
Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes. Mol Cancer Res (2010) 1.60
Intraoperative radiotherapy during breast conserving surgery: a study on 1,822 cases treated with electrons. Breast Cancer Res Treat (2010) 1.59
STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol (2009) 1.59
The IL-6/JAK/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia (2013) 1.58
Early and persistent alterations in the expression of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor alpha mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation. Radiat Res (1996) 1.55
Positive affect and inflammation during radiation treatment for breast and prostate cancer. Brain Behav Immun (2009) 1.54
Transcription factors activated in mammalian cells after clinically relevant doses of ionizing radiation. Oncogene (2003) 1.52
IL-13 signaling via IL-13R alpha2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology (2008) 1.51
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells. Am J Pathol (2001) 1.51
NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment. Cancer Lett (2006) 1.49
The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat (2013) 1.49
Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther (2007) 1.48
Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species. Radiat Res (2006) 1.47
Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res (2006) 1.46
Radiation-induced alterations in cytokine production by skin cells. Exp Hematol (2007) 1.39
Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res (1995) 1.38
Responses of normal cells to ionizing radiation. Semin Radiat Oncol (2007) 1.38
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy. PLoS One (2009) 1.37
Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol (2005) 1.36
Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res (2002) 1.36
Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding. Clin Cancer Res (2008) 1.34
Soluble TNF mediates the transition from pulmonary inflammation to fibrosis. PLoS One (2006) 1.32
Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology (2013) 1.31
TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo. Clin Cancer Res (2011) 1.30
Ionizing radiation promotes migration and invasion of cancer cells through transforming growth factor-beta-mediated epithelial-mesenchymal transition. Int J Radiat Oncol Biol Phys (2011) 1.30
Cytokines in radiobiological responses: a review. Radiat Res (2012) 1.29
Acute induction of inflammatory cytokine expression after gamma-irradiation in the rat: effect of an NF-kappaB inhibitor. Int J Radiat Oncol Biol Phys (2004) 1.28
STAT1 and STAT3 in tumorigenesis: A matter of balance. JAKSTAT (2012) 1.27
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer (2007) 1.26
Radiation, inflammation, and immune responses in cancer. Front Oncol (2012) 1.25
Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation. Int J Radiat Biol (1999) 1.24
Nuclear factor-kappaB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8. Clin Cancer Res (2003) 1.23
Local production of interleukin-4 during radiation-induced pneumonitis and pulmonary fibrosis in rats: macrophages as a prominent source of interleukin-4. Am J Respir Cell Mol Biol (1997) 1.22
Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol (2010) 1.22
IL-8 gene expression and production in human keratinocytes and their modulation by UVB. J Invest Dermatol (1993) 1.21
Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol (2006) 1.20
Induction of acute phase gene expression by brain irradiation. Int J Radiat Oncol Biol Phys (1995) 1.20
Identification of radiation-specific responses from gene expression profile. Oncogene (2002) 1.16
ATM and the catalytic subunit of DNA-dependent protein kinase activate NF-kappaB through a common MEK/extracellular signal-regulated kinase/p90(rsk) signaling pathway in response to distinct forms of DNA damage. Mol Cell Biol (2004) 1.13
Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism. Int J Radiat Oncol Biol Phys (2007) 1.12
Post-radiation increase in VEGF enhances glioma cell motility in vitro. Radiat Oncol (2012) 1.11
Global gene expression profiles reveal an increase in mRNA levels of collagens, MMPs, and TIMPs in late radiation enteritis. Am J Physiol Gastrointest Liver Physiol (2004) 1.09